Application of different post-processing modes of dynamic contrast enhanced magnetic resonance imaging in glioma grading
Neurosciences|更新时间:2026-01-09
|
Application of different post-processing modes of dynamic contrast enhanced magnetic resonance imaging in glioma grading
Journal of Third Military Medical UniversityVol. 43, Issue 23, Pages: 2577-2583(2021)
作者机构:
400042 重庆,陆军军医大学(第三军医大学)大坪医院放射科
作者简介:
基金信息:
the National Key Research and Development Program of China(2018YFC0115004);the General Program of National Natural Science Foundation of China(81871421);the Project of Science and Technology Plan of Chongqing Clinical Research Centre of Imaging and Nuclear Medicine(CSTC2015YFPT-gcjsyjzx0175)
Peng CHEN, Houyi KANG, Letian ZHANG, et al. Application of different post-processing modes of dynamic contrast enhanced magnetic resonance imaging in glioma grading[J]. Journal of Third Military Medical University, 2021, 43(23): 2577-2583.
DOI:
Peng CHEN, Houyi KANG, Letian ZHANG, et al. Application of different post-processing modes of dynamic contrast enhanced magnetic resonance imaging in glioma grading[J]. Journal of Third Military Medical University, 2021, 43(23): 2577-2583. DOI: 10.16016/j.1000-5404.202106043.
Application of different post-processing modes of dynamic contrast enhanced magnetic resonance imaging in glioma grading
探讨磁共振动态对比增强(dynamic contrast enhanced magnetic resonance imaging,DCE-MRI) 的不同后处理模型[Tissue-4D和Omni-Kinetics(OK)软件]在鉴别脑胶质瘤不同级别中的价值。
方法
2
收集本院2013年1月至2019年7月共89例经术后病理证实的胶质瘤患者
其中Ⅱ级29例、Ⅲ级24例、Ⅳ级36例。患者均于术前行DCE-MRI检查,分别用Tissue-4D及OK后处理软件获得相应参数值。运用单因素方差分析比较不同级别胶质瘤参数差异,Spearman等级相关分析不同参数与胶质瘤分级的相关性,受试者工作特征(receiver operating characteristic,ROC)曲线分析各参数的曲线下面积(area under the curve,AUC)。
To explore the diagnostic values of different post-processing modes of dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in the differentiation of glioma grade.
Methods
2
A total of 89 patients with glioma confirmed by postoperative pathology in our hospital from January 2013 to July 2019 were enrolled
including 29 patients of gradeⅡ
24 of grade Ⅲ and 36 of grade Ⅳ. All patients underwent preoperative DCE-MRI examination
and corresponding parameters were collected and processed using post-processing software Tissue-4D and Omni-Kinetics (OK) respectively. One-way ANOVA was adopted to compare the differences of the obtained parameters among glioma of different grades. Spearman rank correlation analysis was performed to analyze the correlation between each parameter and glioma grade
and receiver operating characteristic (ROC) curve was used to evaluate the area under the curve (AUC) of each parameter.
Results
2
In hot spot analysis
the Ktrans values of both post-processing modes
as well as the iAUC value of Tissue-4D and the Vp value of OK were all significantly different among glioma of different grades (
P
<
0.05). The Kep value of grade Ⅳ glioma was obviously lower than that of grade Ⅱ glioma (
P
<
0.05)
while the Ve values of grade Ⅳ and Ⅲ tumors were notably higher than that of gradeⅡ one (
P
<
0.05).
The AUC value of Ktrans (Tissue-4D) was 0.949 in the differentiation of gradeⅡ from grade Ⅳ glioma (
P
<
0.01)
indicating the highest diagnostic efficiency
and the correlation between Ktrans (OK) and glioma grade was the highest (
r
=0.775
P
<
0.01). In the histogram analysis of OK
the 50th percentile of Ktrans value
the mean and the 75th and 90th percentiles of Ve value
the mean
entropy and the 50th percentile of Kep value
as well as the mean value of Vp showed significances in the differentiation of grade Ⅱ from grade Ⅲ and grade Ⅱ from grade Ⅳ glioma (
P
<
0.05). Moreover
the energy
entropy and 50th
75th
90th percentiles of Vp value
and the energy of Kep value were statistically different in the identification of grade Ⅳ from grade Ⅱ and grade Ⅳ from grade Ⅲ (
P
<
0.05).
Conclusion
2
The Ktrans and Ve values of the 2 post-processing modes have rather high diagnostic efficiency for glioma grading in the hotspot analysis
and the histogram analysis of OK software involves more abundant and comprehensive parameters.
关键词
Keywords
references
OIKE T, SUZUKI Y, SUGAWARA K, et al . Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results[J ] . P LoS ONE, 2013, 8(11): e78943. DOI: 10.1371/journal.pone.0078943.
ZHANG J F, LIU H, TONG H P, et al . Clinical applications of contrast-enhanced perfusion MRI techniques in gliomas: recent advances and current challenges[J ] . Contrast Media Mol Imaging, 2017, 2017: 7064120. DOI: 10.1155/2017/7064120.
YAN L F, SUN Y Z, ZHAO S S, et al . Perfusion, diffusion, or brain tumor barrier integrity: which represents the glioma features best?[J ] . Cancer Manag Res, 2019, 12(11): 9989-10000. DOI: 10.2147/CMAR.S197839.
SENGUPTA A, AGARWAL S, GUPTA P K, et al . On differentiation between vasogenic edema and non-enhancing tumor in high-grade glioma patients using a support vector machine classifier based upon pre and post-surgery MRI images[J ] . Eur J Radiol, 2018, 9(106): 199-208. DOI: 10.1016/j.ejrad.2018.07.018.
KHALIFA F, SOLIMAN A, EL-BAZ A, et al . Models and methods for analyzing DCE-MRI: a review[J ] . Med Phys, 2014, 41(12): 124301. DOI: 10.1118/1.4898202.
ZHANG J L, RUSINEK H, BOKACHEVA L, et al . Use of cardiac output to improve measurement of input functi on in quantitative dynamic contrast-enhanced MRI[J ] . J Magn Reson Imaging, 2009, 30(3): 656-665. DOI: 10.1002/jmri.21891.
JIN Y, PENG H, PENG J. Brain glioma localization diagnosis based on magnetic resonance imaging[J]. World Neurosurg, 2021, 149: 325-332. DOI: 10.1016/j.wneu.2020.09.113.
ZHANG H X, SUN Z Q, CHENG Y G, et al . A pilot study of radiomics technology based on X-ray mammography in patients with triple-negative breast cancer[J ] . J Xray Sci Technol, 2019, 27(3): 485-492. DOI: 10.3233/XST-180488.
HUANG J, LI X G, KANG H Y, et al . Dynamic contrast enhanced magnetic resonance imaging and dynamic susceptibility contrast magnetic resonance imaging in grading of glioma[J ] . J Third Mil Med Univ, 2015, 37(7): 672-677. DOI: 10.16016/j.1000-5404.201410173.
GUAN T T, WANG X Y, HOU L, et al . Study on the relationship between DCE-MRI and glioma grade, as well as between DCE-MRI and VEGF expressio n[J ] . J Clin Radiol, 2018, 37(12): 1973-1979. DOI: 10.13437/j.cnki.jcr.2018.12.006.
ABRIGO J M, FOUNTAIN D M, PROVENZALE J M, et al . Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation[J ] . Cochrane Database Syst Rev, 2018, 1(1): CD011551. DOI: 10.1002/14651858.CD011551.pub2
YOU S H, CHOI S H, KIM T M, et al . Differentiation of high-grade from low-grade astrocytoma: improvement in diagnostic accuracy and reliability of pharmacokinetic parameters from DCE MR imaging by using arterial input functions obtained from DSC MR imaging[J ] . Radiology, 2018, 286(3): 981-991. DOI: 10.1148/radiol.2017170764.
ZHAO M, GUO L L, HUANG N, et al . Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging[J ] . Oncol Lett, 2017, 14(5): 5418-5426. DOI: 10.3892/ol.2017.6895.
LEE J Y, AHN K J, LEE Y S, et al . Differentiation of grade Ⅱ and Ⅲ oligodendrogliomas from grade Ⅱ and Ⅲ astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI[J ] . Acta Radiol, 2018, 59(6): 723-731. DOI: 10.1177/0284185117728981.
SENGUPTA A, GUPTA R K, SINGH A. Evaluation of B 1 inhomogeneity effect on DCE-MRI data analysis of brain tumor patients at 3T[J ] . J Transl Med, 2017, 15(1): 242. DOI: 10.1186/s12967-017-1349-7.
BRENDLE C, HEMPEL J M, SCHITTENHELM J, et al . Glioma grading and determination of IDH mutation status and ATRX loss by DCE and ASL perfusion[J ] . Clin Neuroradiol, 2018, 28(3): 421-428. DOI: 10.1007/s00062-017-0590-z.
SANTAROSA C, CASTELLANO A, CONTE G M, et al . Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis[J ] . Eur J Radiol, 2016, 85(6): 1147-1156. DOI: 10.1016/j.ejrad.2016.03.020.
FALK A, FAHLSTRÖM M, ROSTRUP E, et al . Discrimination between glioma grades Ⅱ and Ⅲ in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach[J ] . Neuroradiology, 2014, 56(12): 1031-1038. DOI: 10.1007/s00234-014-1426-z.
HU Y, ZHANG N, YU M H, et al . Volume-based histogr am analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status[J ] . Eur J Radiol, 2020, 131: 109247. DOI: 10.1016/j.ejrad.2020.109247.
HU Y, CHEN Y, WANG J, et al . Non-invasive estimation of glioma IDH1 mutationand VEGF expression by histogram analysis of dynamic contrast-enhanced MRI[J ] . Front Oncol, 2020, 10: 593102. DOI: 10.3389/fonc.2020.593102.
ZHANG H W, LYU G W, HE W J, et al . Differential diagnosis of central lymphoma and high-grade glioma: dynamic contrast-enhanced histogram[J ] . Acta Radiol, 2020, 61(9): 1221-1227. DOI: 10.1177/0284185119896519.
Value of MRI radiomics based on intratumoral and peritumoral heterogeneity in predicting spatial patterns of locally recurrent high-grade gliomas
Hypoxic transcriptional phenotype and cellular ultrastructural changes of tumor-associated macrophages in gliomas
Inhibiting and invasive self-renewal effect of PTPRZ 1 monoclonal antibody on glioma stem cells
Silent information regulator 3 modulates lysosome function to inhibit apoptosis of U87 cell by mTOR pathway
DACT3 promotes ferroptosis of glioma cells through activating BMP4/Smad signaling pathway
Related Author
WANG Hanwei
ZENG Linlan
ZHAO Mimi
LI Xuan
XIE Huan
LI Xiaoguang
YI Liang
WU Yi
Related Institution
Department of Radiology, Chongqing Clinical Research Centre of Imaging and Nuclear Medicine, Faculty of Biomedical Engineering and Imaging Medicine, Army Medical University (Third Military Medical University)
Department of Neurosurgery, Army Medical Center of PLA/Daping Hospital of Third Military Medical University, Chongqing, Faculty of Biomedical Engineering and Imaging Medicine, Army Medical University (Third Military Medical University)
Department of Digital Medicine, Faculty of Biomedical Engineering and Imaging Medicine, Army Medical University (Third Military Medical University)